Best Clinical Trial Management Software for Twilio

Find and compare the best Clinical Trial Management software for Twilio in 2024

Use the comparison tool below to compare the top Clinical Trial Management software for Twilio on the market. You can filter results by user reviews, pricing, features, platform, region, support options, integrations, and more.

  • 1
    Mosio Reviews

    Mosio

    Mosio, Inc.

    $99/month
    Mosio allows research teams to improve subject adhesion, communications, data collection, and communication on mobile's most popular channel, text messaging. Our software helps research teams communicate more efficiently with participants by delivering interactive elements to mobile phones and messaging automation. WHO CAN WE HELP? + Clinical Trial Sponsors (Pharma & Biotech) + Cancer Centers and Clinical Research Organizations + NIH-Funded Studies + Public Health Agencies + Clinical Trial Managers/Directors and Clinical Operations Managers/Directors. Clinical Project Managers. Principal Investigators. Clinical Research (Study). Coordinators. All research staff who regularly communicate with study participants. BENEFITS + Interactive medication reminders and medication compliance alerts + Automate data collection. + Increase engagement and adherence. + Get SMS appointment reminders to fix your no-show problem. + Increase retention with automated check ins
  • 2
    Jeeva eClinical Cloud Reviews

    Jeeva eClinical Cloud

    Jeeva Informatics Solutions

    $100/mo/user
    Jeeva's patent-pending modular system is built on the most powerful cloud platform. One login from any browser-enabled device can be used to remotely screen patients, educate, enroll, send SMS, email and generate evidence including electronic patient-reported outcomes. They are tired of waiting for patient recruitment and retention to happen. It is crucial to provide sufficient evidence of safety and efficacy for investigational new medicines in order to receive regulatory agency approval. Jeeva is a great tool for saving time and money for patients, biopharma sponsors, and long-term follow up studies for gene therapy.
  • Previous
  • You're on page 1
  • Next